Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Here is What Hedge Funds Think About Clorox (CLX)

Hedge funds and other investment firms run by legendary investors like Israel Englander, Jeffrey Talpins and Ray Dalio are entrusted to manage billions of dollars of accredited investors’ money because they are without peer in the resources they use to identify the best investments for their chosen investment horizon. Moreover, they are more willing to invest a greater amount of their resources in small-cap stocks than big brokerage houses, and this is often where they generate their outperformance, which is why we pay particular attention to their best ideas in this space.

The Clorox Company (NYSE:CLX) investors should be aware of an increase in support from the world’s most elite money managers recently. CLX was in 28 hedge funds’ portfolios at the end of December. There were 22 hedge funds in our database with CLX holdings at the end of the previous quarter. Our calculations also showed that CLX isn’t among the 30 most popular stocks among hedge funds.

In the 21st century investor’s toolkit there are a multitude of indicators investors put to use to size up publicly traded companies. A couple of the most useful indicators are hedge fund and insider trading signals. We have shown that, historically, those who follow the top picks of the elite investment managers can outclass the broader indices by a solid amount (see the details here).

Clint Carlson, Carlson Capital

We’re going to take a glance at the recent hedge fund action regarding The Clorox Company (NYSE:CLX).

Hedge fund activity in The Clorox Company (NYSE:CLX)

Heading into the first quarter of 2019, a total of 28 of the hedge funds tracked by Insider Monkey were long this stock, a change of 27% from the previous quarter. The graph below displays the number of hedge funds with bullish position in CLX over the last 14 quarters. With hedge funds’ positions undergoing their usual ebb and flow, there exists an “upper tier” of noteworthy hedge fund managers who were increasing their stakes substantially (or already accumulated large positions).

CLX_mar2019

According to Insider Monkey’s hedge fund database, Cedar Rock Capital, managed by Andy Brown, holds the biggest position in The Clorox Company (NYSE:CLX). Cedar Rock Capital has a $444.5 million position in the stock, comprising 11.9% of its 13F portfolio. On Cedar Rock Capital’s heels is Renaissance Technologies, led by Jim Simons, holding a $359.5 million position; the fund has 0.4% of its 13F portfolio invested in the stock. Remaining peers that are bullish encompass Cliff Asness’s AQR Capital Management, Ken Griffin’s Citadel Investment Group and Phill Gross and Robert Atchinson’s Adage Capital Management.

Consequently, specific money managers have been driving this bullishness. Carlson Capital, managed by Clint Carlson, established the most valuable position in The Clorox Company (NYSE:CLX). Carlson Capital had $18.5 million invested in the company at the end of the quarter. Paul Marshall and Ian Wace’s Marshall Wace LLP also initiated a $2.8 million position during the quarter. The other funds with new positions in the stock are Claes Fornell’s CSat Investment Advisory, Minhua Zhang’s Weld Capital Management, and Dmitry Balyasny’s Balyasny Asset Management.

Let’s now review hedge fund activity in other stocks similar to The Clorox Company (NYSE:CLX). These stocks are Waste Connections, Inc. (NYSE:WCN), Tyson Foods, Inc. (NYSE:TSN), FirstEnergy Corp. (NYSE:FE), and Korea Electric Power Corporation (NYSE:KEP). All of these stocks’ market caps are similar to CLX’s market cap.

Ticker No of HFs with positions Total Value of HF Positions (x1000) Change in HF Position
WCN 28 677487 -2
TSN 38 1426064 -1
FE 39 3732180 1
KEP 9 44600 5
Average 28.5 1470083 0.75

View table here if you experience formatting issues.

As you can see these stocks had an average of 28.5 hedge funds with bullish positions and the average amount invested in these stocks was $1470 million. That figure was $1027 million in CLX’s case. FirstEnergy Corp. (NYSE:FE) is the most popular stock in this table. On the other hand Korea Electric Power Corporation (NYSE:KEP) is the least popular one with only 9 bullish hedge fund positions. The Clorox Company (NYSE:CLX) is not the least popular stock in this group but hedge fund interest is still below average. This is a slightly negative signal and we’d rather spend our time researching stocks that hedge funds are piling on. Our calculations showed that top 15 most popular stocks among hedge funds returned 19.7% through March 15th and outperformed the S&P 500 ETF (SPY) by 6.6 percentage points. Unfortunately CLX wasn’t in this group. Hedge funds that bet on CLX were disappointed as the stock returned 4.9% and underperformed the market. If you are interested in investing in large cap stocks, you should check out the top 15 hedge fund stocks as 13 of these outperformed the market.

Disclosure: None. This article was originally published at Insider Monkey.

DOWNLOAD FREE REPORT: Warren Buffett's Best Stock Picks

Let Warren Buffett, George Soros, Steve Cohen, and Daniel Loeb WORK FOR YOU.

If you want to beat the low cost index funds by 19 percentage points per year, look no further than our monthly newsletter.In this free report you can find an in-depth analysis of the performance of Warren Buffett's entire historical stock picks. We uncovered Warren Buffett's Best Stock Picks and a way to for Buffett to improve his returns by more than 4 percentage points per year.

Bonus Biotech Stock Pick: You can also find a detailed bonus biotech stock pick that we expect to return more than 50% within 12 months.
Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading...